Navigation Links
Beecham in Medical News

Iodex goes to SmithKline Beecham consumer Healthcare

Iodex is the market leader in the pain-balm segment, with a market share of 70 per cent-plus. Iodex faces challenges from local brands like Amrutanjan, Tiger Balm (locally manufactured by Elder Pharma), Zandu Balm and Sensur of Glenmark. // Glaxo SmithKline India (GSK) has decided to transfer...

Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB

...n 2005. In 2004, IBC Conferences named him Chief Scientific Officer of the Year. Prior to joining Wyeth, Dr. Ruffolo spent 17 years at SmithKline beecham (now GSK) and 6 years at Lilly Research Laboratories. During his career, Dr. Ruffolo played a significant role in the discovery and/or development of ...

Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May

...cutive positions with American Cyanamid, Inc., Diane Von Furstenburg, Inc., beecham Cosmetics, Inc., Gale Hayman, Inc., and Savvy International, Inc. In parti...ch of the highly successful Pierre Cardin men's line and the acquisition by beecham Cosmetics of Diane Von Furstenburg, Inc. We believe that Mr. Savage's lead...

John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer

...kcorp, a financial services holding company located in Kentucky. Mr. Davis has worked in various IT positions for companies such as Smith Kline beecham and Blue Cross and Blue Shield of Maryland. He holds an MBA from Drexel University , with a concentration in International Business. About A...

Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer

...anning and business development while at Inotek Pharmaceuticals Corp., Exact Sciences Corp., Pathogenesis Corp. (now part of Novartis), and SmithKline beecham (now part of GlaxoSmithKline). "I am looking forward to working with Dr. Celniker and the rest of the team that she has assembled as we buil...

Watson Pharmaceuticals Reports Third Quarter 2008 Results

...-looking statements. Risperdal(R) is a registered trademark of Johnson & Johnson Corporation. Lamictal(R) is a registered trademark of SmithKline beecham Corporation. The following table presents Watson's results of operations for the three and nine months ended September 30, 2008 and 2007: ...

Smart Balance Announces Marketing Organization Appointment

...ading manufacturer of composite decking. Prior to that he held senior leadership roles with Mead Johnson/Bristol-Myers Squibb, Rite Aid and Smithkline beecham Consumer Healthcare. McWilliams has a BA from Westminister College and an MBA from Harvard Graduate School of Business. The Company issued to McWill...

Paul Capital Partners Promotes Ken Macleod To Partner

...maceutical and biotechnology industries, where he previously held senior management positions over a 15-year career at Serono, Abbott Laboratories and beecham Pharmaceuticals. Prior to joining Paul Capital Partners, Dr. Macleod was a Venture Partner at Schroder Ventures Life Sciences where he was responsible...

Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations

...ons Manager for Scherer DDS (a division of RP Scherer) from 1994 to 1999; and various European clinical research positions with Beecham and SmithKline beecham and GH Besselaar from 1983-1994. Dr. Clarke holds a Bachelors of Science in Pharmacology from University of Sunderland and a PhD in Psychopharmacology...

PhRMA Celebrates 20th Anniversary of Discoverers Award

...es exemplify the best among research based company scientists today. This year, PhRMA presented the Discoverers Award to the three then SmithKline beecham scientists who discovered the prescription drug Coreg. The recipients of the award are Eliot Ohlstein, Ph.D., Senior Vice President and head of the Ca...
Beecham in Medical Technology

Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results

...ears of clinical development experience, including previous positions at Avigenics Inc., Cephalon, Inc., MDS Proteomics, Inc. and SmithKline beecham Pharmaceuticals. Conference Call and Webcast Information Memory Pharmaceuticals will hold a conference call on March 6, 2008, at 9:00 a.m. EST to d...
Beecham in Biological Technology

Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors

...lopment, and was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline beecham with Glaxo Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development. Dr. Greig also serves ...

Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development

...toral Fellowship at The Wistar Institute. Previous to joining Axial Biotech, Dr. Macina worked with the molecular diagnostics department at SmithKline beecham in the discovery and characterization of novel genes differentially expressed in different cancers. "Dr. Macina's decision to join Axial streng...

Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS

...roduct development, R&D operations, corporate development and strategy, as well as new product research. Prior to Nektar, he worked at SmithKline beecham Pharmaceuticals in King of Prussia, PA, where he focused in the areas of pharmaceutical technology formulation sciences and product development. ...

GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.

...itation and the tender offer to buy shares of Genelabs is only being made pursuant to the Offer to Purchase and related materials that GSK, SmithKline beecham Corporation and Gemstone Acquisition Corporation filed with the Securities and Exchange Commission (SEC) on November 12, 2008 and as subsequently amen...

GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.

...ffer in connection with the addition of SmithKline beecham Corporation, a wholly-owned subsidiary of GSK, as ...s, Gemstone Acquisition Corporation and SmithKline beecham Corporation. All other terms and condition...urchase and related materials that GSK, SmithKline beecham Corporation and Gemstone Acquisition Corporation f...

GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.

...pursuant to a previously announced Agreement and Plan of Merger dated October 29, 2008 among Genelabs, Gemstone Acquisition Corporation and SmithKline beecham Corporation, a wholly-owned subsidiary of GSK. All other terms and conditions of the tender offer remain the same, including the condition tha...

GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.

...der offer is being made pursuant to a previously announced Agreement and Plan of Merger dated October 29, 2008 among Genelabs, Gemstone and SmithKline beecham Corporation, a wholly-owned subsidiary of GSK. The Genelabs board of directors has unanimously determined that the tender offer and the merger are f...

David M. Stout Joins NanoBio Corporation's Board of Directors

...ing to respond to a global influenza pandemic. Prior to his tenure at GSK, Mr. Stout held executive leadership positions at Glaxo Wellcome, SmithKline beecham and Schering-Plough Corporation. About NanoBio NanoBio(R) Corporation is a privately held biopharmaceutical company focused on developing and comm...

QuoNova Global Executive Appointments

...ntree Laboratories, a $100 million deal. Michael's background includes business development roles with International Clinical Laboratories, SmithKline beecham Laboratories and Integrated Genetics/Genzyme Corporation. He has a BA in Chemistry from Assumption College in Worcester, Massachusetts and an MBA from...

Warner Chilcott Reports the Death of Its Director James Andress

...ng he also served as the co-chairman of the audit committee of the board of directors. Mr. Andress was a former Chairman of the Pharmaceuticals Group, beecham Group, plc, former Chairman, Healthcare Products and Services of SmithKline Beecham, plc and former President and Chief Operating Officer of Sterling ...
Other Tags
(Date:9/1/2014)... Steven Reinberg HealthDay Reporter ... a head-to-head comparison, an experimental drug was more effective ... heart failure patients. According to the study authors, ... benefit of the new drug, dubbed LCZ696. ... standard medication, enalapril (Vasotec), either died or were hospitalized ...
(Date:9/1/2014)... MONDAY, Sept. 1, 2014 (HealthDay News) -- Watching action shows ... study contends. People eat much more snack food while ... to the Cornell University researchers. "We find that if ... see more action too," study author Aner Tal, of the ... release. "In other words, the more distracting the program is, ...
(Date:9/1/2014)... 01, 2014 Currently, scientists continue ... treatments for Alzheimer's disease (AD), which reflects their ... regarding the diagnosis of the disease, especially in ... appropriate diagnostic tests. In 2014, after decades ... breakthroughs in the medicine world, there are still ...
(Date:9/1/2014)... More than 200 Lipitor lawsuit ( ... litigation that continues to progress in the U.S. District ... , A federal Case List published on August ... cholesterol medication by plaintiffs who developed Type 2 diabetes ... Inc. failed to adequately warn patients and their doctors ...
(Date:9/1/2014)... 2014 The B-cell non-Hodgkin’s Lymphoma (NHL) ... major markets (the US, France, Italy, Germany, Spain and ... billion by 2018. , The competitive landscape in the ... Spain and the UK is poised to undergo a ... the four largest B-cell NHL indications, which includes Diffuse ...
Breaking Medicine News(10 mins):Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 2Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 3Health News:Action-Packed TV a Threat to Your Waistline? 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org 4
(Date:8/29/2014)... University of Texas Medical Branch at Galveston has gone on ... completely protect monkeys against a lethal dose of Ebola virus ... the disease is severe. , Thomas Geisbert, professor of microbiology ... discussing advances in Ebola treatment research. The filoviruses known as ... of pathogens, with fatality rates of up to 90 percent. ...
(Date:8/29/2014)... connections in transcription factor networks (TFNs) to evaluate the ... in PLOS Computational Biology in August. ... a network,s resilience against mutations. , "In simulations, ... models has a greater effect on robustness than varying ... Dov A. Pechenick, PhD, lead author and former researcher ...
(Date:8/29/2014)... This news release is available in German . ... of chemical signals between organisms is considered the oldest ... social interactions between conspecifics, for example, the sexual attraction ... trigger social responses and to coordinate reproductive behavior in ... at the University of the Algarve in Faro, Portugal, ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Assortativity signatures of transcription factor networks contribute to robustness 2Ready for mating at the right time 2Ready for mating at the right time 3
Other Contents